PLAY PODCASTS
Biomarkers in Ovarian Cancer: Expert Discussion of Options for First-line Maintenance Therapy
Episode 25

Biomarkers in Ovarian Cancer: Expert Discussion of Options for First-line Maintenance Therapy

Listen to Prof Isabelle Ray Coquard and Bradley J. Monk, MD, FACS, FACOG, discuss current treatment options for first-line maintenance therapy for patients with advanced ovarian cancer.

Decera Clinical Education Oncology Podcast · Prof Isabelle Ray Coquard, Bradley J. Monk MD FACS FACOG

October 2, 202019m 5s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, Isabelle Ray Coquard, MD, PhD and Bradley J. Monk, MD, FACS, FACOG, discuss current first-line maintenance therapy options for patients with advanced ovarian cancer. 

Presenters:

Prof Isabelle Ray Coquard
Professor of Department of Medical Oncology
Clinical Science Institute of the Léon Bérard Center
Lyon, France

Bradley J. Monk MD, FACS, FACOG
Professor
Division of Gynecologic Oncology
Arizona Oncology (US Oncology Network)
University of Arizona College of Medicine--Phoenix
Creighton University School of Medicine at St Joseph's Hospital
Phoenix, Arizona

Content based on an online CME program supported by an educational grant from GlaxoSmithKline.

Link to full program:
https://bit.ly/2Scnp2N  


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

paola-1germline testingsolo 1primagog 218maintenance therapyepithelial ovarian cancerhomologous recombinationniraparibhigh grade serousbradley j. monkhrdolaparibfirst-line therapybrca-likeparpbevacizumabhr proficientisabelle ray coquardhr deficientbrcapoly adp-ribose polymeraseovarian cancerhomologous recombination deficiency